IRD
Opus Genetics
IRD
IRD
41 hedge funds and large institutions have $6.69M invested in Opus Genetics in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.65% less ownership
Funds ownership: 12.54% → 10.9% (-1.6%)
17% less capital invested
Capital invested by funds: $8.07M → $6.69M (-$1.38M)
Holders
41
Holding in Top 10
–
Calls
$238K
Puts
$79K
Top Buyers
| 1 | +$162K | |
| 2 | +$126K | |
| 3 | +$97K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$68K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$45K |
Top Sellers
| 1 | -$232K | |
| 2 | -$222K | |
| 3 | -$177K | |
| 4 |
DC
Diametric Capital
Boston,
Massachusetts
|
-$122K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$78.9K |